A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme.
Phase of Trial: Phase I/II
Latest Information Update: 21 Sep 2011
At a glance
- Drugs Everolimus (Primary)
- Indications Glioblastoma
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Novartis
- 10 Jun 2017 Biomarkers information updated
- 26 Jul 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 26 Jul 2011 Actual trial end date changed from 1 Dec 2009 to 1 Aug 2009 as reported by ClinicalTrials.gov.